Yatin Suneja
Stock Analyst at Guggenheim
(4.74)
# 212
Out of 5,182 analysts
171
Total ratings
60.9%
Success rate
31.47%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IFRX InflaRx | Reiterates: Buy | $14 | $1.61 | +769.57% | 8 | Apr 21, 2026 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $125 | $76.39 | +63.63% | 5 | Apr 13, 2026 | |
| NMRA Neumora Therapeutics | Reiterates: Buy | $14 | $2.22 | +530.63% | 4 | Mar 31, 2026 | |
| DBVT DBV Technologies | Reiterates: Buy | $51 | $20.39 | +150.12% | 3 | Mar 27, 2026 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $220 → $245 | $187.40 | +30.74% | 11 | Mar 25, 2026 | |
| CABA Cabaletta Bio | Maintains: Buy | $15 → $16 | $2.91 | +449.83% | 7 | Mar 24, 2026 | |
| IMUX Immunic | Initiates: Buy | $70 | $9.98 | +601.40% | 1 | Mar 24, 2026 | |
| ZBIO Zenas BioPharma | Maintains: Buy | $45 → $55 | $18.59 | +195.86% | 4 | Mar 17, 2026 | |
| ACET Adicet Bio | Maintains: Buy | $128 → $100 | $7.93 | +1,161.03% | 4 | Mar 13, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $100 → $200 | $87.16 | +129.46% | 3 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $39.21 | +27.52% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $25 | $11.59 | +115.70% | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,160 → $1,120 | $783.74 | +42.90% | 14 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $760 → $800 | $330.99 | +141.70% | 5 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $865 → $975 | $744.44 | +30.97% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $246 | $180.67 | +36.16% | 4 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $27.85 | +7.72% | 4 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $44 | $28.62 | +53.74% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $14.42 | +246.74% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $32 | $24.75 | +29.29% | 3 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.48 | +331.65% | 1 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $66.59 | +50.17% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $111.90 | +34.05% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $16.85 | +18.69% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $26.74 | +180.48% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $128.04 | +36.68% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.44 | +485.59% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $19.60 | +48.00% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.41 | +177.26% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $29.95 | +50.25% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $22.30 | -10.31% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.47 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $71.90 | -9.60% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $33.66 | +167.38% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.09 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $54.26 | -9.69% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $13.60 | +304.41% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.03 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $15.88 | +51.13% | 1 | May 31, 2022 |
InflaRx
Apr 21, 2026
Reiterates: Buy
Price Target: $14
Current: $1.61
Upside: +769.57%
Oruka Therapeutics
Apr 13, 2026
Reiterates: Buy
Price Target: $125
Current: $76.39
Upside: +63.63%
Neumora Therapeutics
Mar 31, 2026
Reiterates: Buy
Price Target: $14
Current: $2.22
Upside: +530.63%
DBV Technologies
Mar 27, 2026
Reiterates: Buy
Price Target: $51
Current: $20.39
Upside: +150.12%
Axsome Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $220 → $245
Current: $187.40
Upside: +30.74%
Cabaletta Bio
Mar 24, 2026
Maintains: Buy
Price Target: $15 → $16
Current: $2.91
Upside: +449.83%
Immunic
Mar 24, 2026
Initiates: Buy
Price Target: $70
Current: $9.98
Upside: +601.40%
Zenas BioPharma
Mar 17, 2026
Maintains: Buy
Price Target: $45 → $55
Current: $18.59
Upside: +195.86%
Adicet Bio
Mar 13, 2026
Maintains: Buy
Price Target: $128 → $100
Current: $7.93
Upside: +1,161.03%
Dianthus Therapeutics
Mar 4, 2026
Maintains: Buy
Price Target: $100 → $200
Current: $87.16
Upside: +129.46%
Mar 3, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $39.21
Upside: +27.52%
Feb 27, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $11.59
Upside: +115.70%
Feb 27, 2026
Maintains: Buy
Price Target: $1,160 → $1,120
Current: $783.74
Upside: +42.90%
Feb 10, 2026
Maintains: Buy
Price Target: $760 → $800
Current: $330.99
Upside: +141.70%
Feb 9, 2026
Maintains: Buy
Price Target: $865 → $975
Current: $744.44
Upside: +30.97%
Feb 9, 2026
Maintains: Buy
Price Target: $185 → $246
Current: $180.67
Upside: +36.16%
Feb 9, 2026
Maintains: Buy
Price Target: $28 → $30
Current: $27.85
Upside: +7.72%
Feb 9, 2026
Maintains: Buy
Price Target: $41 → $44
Current: $28.62
Upside: +53.74%
Feb 2, 2026
Initiates: Buy
Price Target: $50
Current: $14.42
Upside: +246.74%
Jan 7, 2026
Maintains: Buy
Price Target: $18 → $32
Current: $24.75
Upside: +29.29%
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $3.48
Upside: +331.65%
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $66.59
Upside: +50.17%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $111.90
Upside: +34.05%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $16.85
Upside: +18.69%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $26.74
Upside: +180.48%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $128.04
Upside: +36.68%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $4.44
Upside: +485.59%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $19.60
Upside: +48.00%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $5.41
Upside: +177.26%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $29.95
Upside: +50.25%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $22.30
Upside: -10.31%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.47
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $71.90
Upside: -9.60%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $33.66
Upside: +167.38%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.09
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $54.26
Upside: -9.69%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $13.60
Upside: +304.41%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $7.03
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $15.88
Upside: +51.13%